Neogen Chemicals Q3 Results Review - Attractive Entry Point Likely In The Near Term: Nirmal Bang

Nirmal Bang Report

Neogen Chemicals Ltd.'s Q3 operating performance came significantly below our estimates mainly on account of continued slowdown in agrochemicals and pharmaceuticals segments impacting the base business.

Since aggressive capex expansion for the Battery chemicals vertical is coupled with pressure in the existing business due to global weakness, B/S looks stretched.

However, on the flipside, with the ongoing capacity addition, Neogen Chemicals is poised to grow its Ebitda by ~6 times from FY24E at peak with a blended return on invested capital of ~19%, in our view.

While we remain structurally positive on the business, near-term uncertainties could offer a better entry point, in our view. Maintain Acc.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.